Found: 14
Select item for more details and to access through your institution.
Commentary: Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.
- Published in:
- Frontiers in Synaptic Neuroscience, 2018, p. 1, doi. 10.3389/fnsyn.2017.00018
- By:
- Publication type:
- Article
NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.
- Published in:
- Neurotoxicity Research, 2020, v. 37, n. 3, p. 491, doi. 10.1007/s12640-019-00147-2
- By:
- Publication type:
- Article
Anti-inflammatory Activity of Ursolic Acid in MPTP-Induced Parkinsonian Mouse Model.
- Published in:
- Neurotoxicity Research, 2019, v. 36, n. 3, p. 452, doi. 10.1007/s12640-019-00038-6
- By:
- Publication type:
- Article
Quality Control in Huntington's Disease: a Therapeutic Target.
- Published in:
- Neurotoxicity Research, 2019, v. 36, n. 3, p. 612, doi. 10.1007/s12640-019-00087-x
- By:
- Publication type:
- Article
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.
- Published in:
- Neurotoxicity Research, 2019, v. 35, n. 3, p. 775, doi. 10.1007/s12640-019-0003-y
- By:
- Publication type:
- Article
Oleuropein confers neuroprotection against rotenone-induced model of Parkinson's disease via BDNF/CREB/Akt pathway.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-29287-4
- By:
- Publication type:
- Article
BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02922-7
- By:
- Publication type:
- Article
BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02922-7
- By:
- Publication type:
- Article
Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
- Published in:
- NeuroMolecular Medicine, 2019, v. 21, n. 1, p. 42, doi. 10.1007/s12017-018-08521-7
- By:
- Publication type:
- Article
Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2020, p. 1, doi. 10.1155/2020/6571484
- By:
- Publication type:
- Article
Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
- Published in:
- Neurochemical Research, 2022, v. 47, n. 7, p. 1816, doi. 10.1007/s11064-022-03591-3
- By:
- Publication type:
- Article
Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
- Published in:
- Neurochemical Research, 2021, v. 46, n. 7, p. 1618, doi. 10.1007/s11064-021-03334-w
- By:
- Publication type:
- Article
Neuroprotective effects of Withania somnifera in BPA induced-cognitive dysfunction and oxidative stress in mice.
- Published in:
- Behavioral & Brain Functions, 2019, v. 15, n. 1, p. N.PAG, doi. 10.1186/s12993-019-0160-4
- By:
- Publication type:
- Article
Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 10, p. 1293, doi. 10.1007/s00210-019-01670-x
- By:
- Publication type:
- Article